Universal Health Services (UHS)
(Delayed Data from NYSE)
$239.67 USD
-1.57 (-0.65%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $239.65 -0.02 (-0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value A Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$239.67 USD
-1.57 (-0.65%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $239.65 -0.02 (-0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value A Growth F Momentum A VGM
Zacks News
C.R. Bard (BCR) to Report Q4 Earnings: A Surprise in Store?
by Zacks Equity Research
Delving deeper into the fundamentals of C.R. Bard (BCR), let's see how things are shaping up prior to this quarter.
Is a Surprise in Store for Hologic (HOLX) in Q1 Earnings?
by Zacks Equity Research
Hologic Inc. (HOLX) is slated to report first-quarter fiscal 2017 financial results on Feb 1, after the closing bell.
Myriad Genetics (MYGN) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Myriad Genetics, Inc.(MYGN) is expected to report second-quarter fiscal 2017 results on Feb 7, after the closing bell.
Is Universal Health (UHS) a Great Stock for Value Investors?
by Zacks Equity Research
Let's find out if Universal Health Services, Inc. (UHS) stock is a good choice for value-oriented investors.
Why You Should Hold onto Acadia Healthcare (ACHC) Stock
by Zacks Equity Research
Shares of Acadia Healthcare Company, Inc. (ACHC), have recently gained momentum. Month to date, the stock has returned 15.4% compared with the Zacks categorized Hospitals industry's increase of 10.8%.
Buy these 5 Low Leverage Stocks to Be Safe
by Zacks Equity Research
Considering the fact that debt ridden companies are more vulnerable at times of volatility, it is safe to avoid those for achieving optimal returns.
IDEXX Laboratories (IDXX) Q4 Earnings: What's in Store?
by Zacks Equity Research
IDEXX Laboratories, Inc. (IDXX) is slated to report fourth-quarter 2016 results on Feb 2, before the opening bell.
Will Boston Scientific (BSX) Pull a Surprise in Q4 Earnings?
by Zacks Equity Research
Boston Scientific Corporation (BSX) is scheduled to report fourth-quarter and full-year 2016 results before the opening bell on Feb 2.
Edward Lifesciences (EW): What's in Store in Q4 Earnings?
by Zacks Equity Research
Edward Lifesciences Corp. (EW) is scheduled to report fourth-quarter and full-year 2016 earnings results after market close on Feb 1, 2017.
Will Thermo Fisher (TMO) Beat Earnings Estimates in Q4?
by Zacks Equity Research
Thermo Fisher Scientific, Inc. (TMO) is scheduled to report fourth-quarter and full-year 2016 results before the opening bell on Jan 31.
Illumina (ILMN) Q4 Earnings: A Beat in Store for the Stock?
by Zacks Equity Research
We expect Illumina Inc (ILMN) to beat expectations when it reports fourth-quarter 2016 results after the closing bell on Jan 31.
Boost Your Portfolio by Betting on Stocks with Rising P/E
by Zacks Equity Research
Inside the top-ranked stocks that can beat earnings estimates in their next releases.
Can HCA Holdings Retain its Business Strength in 2017?
by Zacks Equity Research
While HCA Holdings (HCA) gave a strong outlook for its top and bottom lines, details on admission in the fourth quarter were not so appealing.
HCA Holdings Holds Promise Despite Headwinds: Here's Why
by Zacks Equity Research
The uptrend in HCA Holdings Inc. (HCA) explains its attractiveness in an uncertainty-ridden industry.
HCA Holdings Well Poised for Growth In Spite of Headwinds
by Zacks Equity Research
HCA Holdings (HCA) scale and diversified business mix provides it a competitive advantage.
Universal Health to Buy Cambian Group Arm for UK Expansion
by Zacks Equity Research
In an effort to expand its presence in the U.K., Universal Health Services, Inc. (UHS) is planning to buy the adult services division of Cambian Group.
How Low Does This Correction Go?
by John Blank
The latest valuation correction may or may not be over.
Top Stocks with Big Potential Catch-Up Moves
by Kevin Matras
Kevin Matras shows how to find the top stocks in the top sectors with the biggest potential catch-up price moves. Highlighted stocks include LG, SHOO, UHS, VRSK and WTFC.